Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.5 |